BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.82
0.32%
US Tech 100
20,240.00
-0.65%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.3991
-0.12%
Bitcoin
95,985.80
0.34%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Relmada Therapeutics Inc (RLMD)

  7. Relmada Therapeutics Inc (RLMD) Financials

Relmada Therapeutics Inc

Relmada Therapeutics Inc (RLMD)

NASDAQ
2.90
0.18
(6.62%)
Closed November 29 3:00PM
Delayed by 15 minutes
2.889
-0.011
(-0.38%)
After Hours: 6:59PM
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly
Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -45.51M-38.74M-38.7M-28.15M-26.03M-22.69M-26.83M-22.99M
Pre Tax Income -39.94M-39.42M-37.95M-26.32M-25.3M-22M-25.17M-21.83M
Net Income -39.94M-39.42M-37.95M-26.32M-25.3M-22M-25.17M-21.83M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -39.16M-38.74M-32.35M-28.15M-26.03M-22.69M-26.83M-22.99M
EBITDA -45.51M-38.74M-38.7M-28.15M-26.03M-22.69M-26.83M-22.99M
Year End December 30 2023 20172018201920192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -7.22M-6.92M-12.73M-8.27M-60.84M-125.7M-161.25M-103.7M
Pre Tax Income -6.29M-8.96M-17.32M-8.2M-59.46M-125.75M-157.04M-98.79M
Net Income -6.29M-8.96M-17.32M-8.2M-59.46M-125.75M-157.04M-98.79M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.502-0.714-0.444-0.567-3.64-4.533-5.218-3.282
EBIT -7M-6.92M-16.5M-8.27M-60.84M-125.7M-154.9M-103.7M
EBITDA -7.22M-6.92M-12.73M-8.27M-60.84M-125.7M-161.25M-103.7M

Your Recent History

NASDAQ
RLMD
Relmada Therapeutics
BIT
P1S6L5
BNP Paribas Issuance
BIT
S15548
Societe Generale
BIT
UC277W
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68